These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35484574)

  • 1. CircCRIM1 promotes nasopharyngeal carcinoma progression via the miR-34c-5p/FOSL1 axis.
    He W; Zhou X; Mao Y; Wu Y; Tang X; Yan S; Tang S
    Eur J Med Res; 2022 Apr; 27(1):59. PubMed ID: 35484574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal carcinoma derived exosomes regulate the proliferation and migration of nasopharyngeal carcinoma cells by mediating the miR-99a-5p BAZ2A axis.
    Zhou XJ; Xu HM; Huang GS; Lin BR
    Braz J Otorhinolaryngol; 2024; 90(1):101343. PubMed ID: 37925811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of miR-34c-5p inhibits nasopharyngeal carcinoma cells by mediating NOTCH1.
    Xu X; Yan H; Zhang L; Liu J; Huang Y; Cheng H
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32458967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1.
    Wu Y; Zhang X; Liu C; Li Z; Wen Y; Zheng R; Xu C; Tian J; Wei L; Wang J; Yan Q; Zheng X; Ma J
    J Biol Chem; 2023 Sep; 299(9):105082. PubMed ID: 37495108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircCRIM1 promotes ovarian cancer progression by working as ceRNAs of CRIM1 and targeting miR-383-5p/ZEB2 axis.
    Du Y; Liu X; Zhang S; Chen S; Guan X; Li Q; Chen X; Zhao Y
    Reprod Biol Endocrinol; 2021 Nov; 19(1):176. PubMed ID: 34847936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1.
    Hong X; Liu N; Liang Y; He Q; Yang X; Lei Y; Zhang P; Zhao Y; He S; Wang Y; Li J; Li Q; Ma J; Li Y
    Mol Cancer; 2020 Feb; 19(1):33. PubMed ID: 32061262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of lncRNA SNHG16 Attenuates the Proliferation and Radioresistance of Nasopharyngeal Carcinoma Cells by Mediating miR-31-5p/SFN Axis.
    Zhang W; Zhou X; Tang Z; Fu L; Zou S; Tang S
    Radiat Res; 2023 Feb; 199(2):124-131. PubMed ID: 36520963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.
    Yin W; Shi L; Mao Y
    J Biochem; 2019 Nov; 166(5):433-440. PubMed ID: 31350893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SNHG7 promotes the proliferation of nasopharyngeal carcinoma by miR-514a-5p/ELAVL1 axis.
    Hu W; Li H; Wang S
    BMC Cancer; 2020 May; 20(1):376. PubMed ID: 32370736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA circCRIM1 suppresses lung adenocarcinoma cell migration, invasion, EMT, and glycolysis through regulating miR-125b-5p/BTG2 axis.
    Zhang SJ; Ma J; Wu JC; Hao ZZ; Zhang YA; Zhang YJ
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3761-3774. PubMed ID: 32329853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA LUADT1 promotes nasopharyngeal carcinoma cell proliferation and invasion by downregulating miR-1207-5p.
    Jiang N; Zhao L; Zong D; Yin L; Wu L; Chen C; Song X; Zhang Q; Jiang X; He X; Feng J
    Bioengineered; 2021 Dec; 12(2):10716-10728. PubMed ID: 34738862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-26a-5p suppresses nasopharyngeal carcinoma progression by inhibiting PTGS2 expression.
    Cai B; Qu X; Kan D; Luo Y
    Cell Cycle; 2022; 21(6):618-629. PubMed ID: 35073820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory Mechanism of lncRNA CTBP1-AS2 in Nasopharyngeal Carcinoma Cell Proliferation and Apoptosis via the miR-140-5p/BMP2 Axis.
    Huang B; Li Y; Deng Z; Lan G; Si Y; Zhou Q
    Protein Pept Lett; 2022; 29(7):621-630. PubMed ID: 35894463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircCRIM1 mediates proliferation, migration, and invasion of trophoblast cell through regulating miR-942-5p/IL1RAP axis.
    Yu F; Xing J; Li L; Xiang M
    Am J Reprod Immunol; 2023 Jul; 90(1):e13699. PubMed ID: 37382169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3.
    Yin L; Chen J; Ma C; Pei S; Du M; Zhang Y; Feng Y; Yin R; Bian X; He X; Feng J
    Cell Death Dis; 2020 Jul; 11(7):562. PubMed ID: 32703944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
    Li YQ; Ren XY; He QM; Xu YF; Tang XR; Sun Y; Zeng MS; Kang TB; Liu N; Ma J
    Cell Death Dis; 2015 Jan; 6(1):e1618. PubMed ID: 25611392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
    Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
    BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG1 promotes nasopharyngeal carcinoma development via targeting miR-424-5p.
    Zhou Z; Chen Y
    Histol Histopathol; 2023 Aug; 38(8):953-963. PubMed ID: 36727428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes overexpressing miR-34c inhibit malignant behavior and reverse the radioresistance of nasopharyngeal carcinoma.
    Wan FZ; Chen KH; Sun YC; Chen XC; Liang RB; Chen L; Zhu XD
    J Transl Med; 2020 Jan; 18(1):12. PubMed ID: 31915008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.